日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models.

双重 BCL2/BCL-XL 抑制剂 AZD0466 在急性淋巴细胞白血病临床前模型中的抗白血病疗效

Kannan Sankaranarayanan, Li Yizhen, Baran Natalia, Yang Xu, Ghotbaldini Sanaz, Zhang Tatarata Qi, Yoshimura Satoshi, Li Zhenhua, Hsiao YuChih, Balachander Srividya, Andersen Courtney L, Cidado Justin, Yu Jiyang, Jain Nitin, Yang Jun J, Konopleva Marina

Design and optimisation of dendrimer-conjugated Bcl-2/x(L) inhibitor, AZD0466, with improved therapeutic index for cancer therapy

设计和优化树状聚合物偶联的Bcl-2/x(L)抑制剂AZD0466,以提高其在癌症治疗中的治疗指数

Patterson, Claire M; Balachander, Srividya B; Grant, Iain; Pop-Damkov, Petar; Kelly, Brian; McCoull, William; Parker, Jeremy; Giannis, Michael; Hill, Kathryn J; Gibbons, Francis D; Hennessy, Edward J; Kemmitt, Paul; Harmer, Alexander R; Gales, Sonya; Purbrick, Stuart; Redmond, Sean; Skinner, Matthew; Graham, Lorraine; Secrist, J Paul; Schuller, Alwin G; Wen, Shenghua; Adam, Ammar; Reimer, Corinne; Cidado, Justin; Wild, Martin; Gangl, Eric; Fawell, Stephen E; Saeh, Jamal; Davies, Barry R; Owen, David J; Ashford, Marianne B